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Abstract
Postoperative antibiotics are recommended after appen-
dectomy for complex appendicitis to reduce infectious com-
plications. The duration of this treatment varies considerably 
between and even within institutions. The aim of this review 
was to critically appraise studies on duration of antibiotic 
treatment following appendectomy for complex appendici-
tis. A systematic literature search according to the PRISMA 
guidelines was performed. Comparative studies evaluating 
different durations of postoperative antibiotic therapy. Pri-
mary endpoint was intra-abdominal abscess (IAA) after ap-
pendectomy. Secondary endpoints were surgical site infec-
tion, readmission and length of hospital stay. The quality of 
evidence was assessed with the Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE) 
tool. Pooled event rates were calculated using a random-ef-
fects model. Nine studies reporting 2006 patients with com-
plex appendicitis were included. The methodological quality 
of the included articles was poor. IAA was seen in 138 pa-
tients (8,6%). Meta-analysis revealed a statistically significant 
difference in IAA incidence between antibiotic treatment of 
≤5 vs. >5 days (risk ratio (OR) 0.36 [95% CI 0.23–0.57] (p < 
0.0001)) but not between ≤3 vs. >3 days (OR 0.81 [95% CI 
0.38–1.74] (p = 0.59)). Descriptive statistics were used for sec-
ondary endpoints. The duration of postoperative antibiotic 
treatment is not associated with IAA following appendec-
tomy for complex appendicitis. © 2019 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Appendicitis is one of the most common acute gastro-
intestinal inflammatory disorders in children and adults, 
often requiring surgery and hospitalization [1–3]. In the 
Netherlands, approximately 14,000 patients undergo an 
appendectomy for suspected appendicitis annually [4]. 
Acute appendicitis is classified into 2 distinct types: sim-
ple and complex. A simple appendicitis is a suppurative 
or phlegmonous appendicitis (transmural inflammation, 
ulceration, or thrombosis) with or without extramural 
pus. A complex appendicitis includes a gangrenous 
(transmural inflammation with necrosis) appendicitis, a 
perforated appendicitis and/or appendicitis with abscess 
formation (pelvic/abdominal) [5]. Some 25–30% of all 
appendicitis is complex [6–12]. A Cochrane Systematic 
review revealed that antibiotic prophylaxis is effective in 
the prevention of postoperative complications in patients 
undergoing appendectomy for simple and complex ap-
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pendicitis, whether the administration is given pre, peri- 
or postoperatively [13]. Complex appendicitis is associ-
ated with increased risk of infectious complications after 
appendectomy [14–17]. Therefore, in addition to preop-
erative antibiotic prophylaxis, guidelines recommend 
postoperative antibiotic treatment for complex appendi-
citis. There is considerable variability in the route of ad-
ministration (IV or oral), agents, dosage and duration of 
postoperative antibiotics practiced worldwide [18–21].
According to a nationwide study from the  Netherlands 
in 2014, the majority of patients (65%) with a complex 
appendicitis are prescribed 5 days of postoperative anti-
biotic treatment. Ultimately, almost 80% of patients actu-
ally receive antibiotics for 5 days or more [22]. Treatment 
duration varied from 2 to 10 days [22]. In a survey among 
Dutch surgeons and residents, postoperative antibiotics 
were given for 3 days (by 58% of surgeons) or 5 days (by 
40% of surgeons) [23]. Restricting postoperative antibi-
otics to < 3 days was uncommon in hospital protocols 
(2.5%), but 31 per cent of surgeons or residents indicated 
that would be favoured by them [23]. A survey sent to all 
practicing paediatric surgeons in North  America to as-
sess the management of perforated appendicitis (in 2003) 
also showed a wide variation in the postoperative dura-
tion of antibiotic treatment [24]. In a more recent Amer-
ican cohort study among children, 66% of patients with 
perforated appendicitis received 5 or more days of intra-
venous antibiotics [25]. And in 92% of these patients, oral 
antibiotics were prescribed in addition to the intravenous 
treatment, which led to a median total course of 13 days 
[25]. 
A duration of 3–5 days best reflects current common 
practice in the Netherlands and is generally considered 
safe and effective internationally as well [8, 12, 22, 23]. An 
increasing amount of evidence indicates that a shorter 
duration may suffice, especially if certain discharge crite-
ria are met [6, 8, 10, 22, 23, 26–40]. 
In 2015, the European Association of Endoscopic Sur-
gery initiated a consensus meeting on the management of 
acute appendicitis [41]. No recommendation could be 
made regarding the duration or route of postoperative 
antibiotics for complex appendicitis due to the lack of 
studies. To reduce the length of hospital stay (LOS), costs, 
and the risk of developing antimicrobial resistance, it is 
important to establish a short but safe and effective anti-
biotic regimen. The aim of this study was to review the 
literature regarding duration of postoperative antibiotic 
treatment for complex appendicitis and its effect on the 
rate of infectious complications, hospital stay and read-
mission in both children and adults.
Methods
This study was reported according to the preferred reporting 
items for systematic reviews and meta-analyses guidelines for re-
porting systematic reviews and meta-analyses [42].
Search Strategy
A comprehensive literature search was performed on February 
27, 2018. Databases from the National Library of Medicine 
 (MEDLINE ovid), the Cochrane Library, Web of Science, Embase, 
PubMed and Google Scholar were searched from inception. Trial 
registries www.clinicaltrial.gov and the World Health Organiza-
tion International Clinical Trials Portal [43] were also searched to 
identify unpublished trials. Search terms included: “appendicitis”, 
“appendectomy”, “antibiotics”, “anti-bacterial agents”, “anti-in-
fective agents”, “postoperative period” and “postoperative care”. A 
librarian performed the search. The supporting information (on-
line suppl. Appendix S1; for all online suppl. material, see www.
karger.com/doi/10.1159/000497482) outlines the complete search 
strategy. Manual reference checks of included papers were per-
formed to check for relevant studies. The literature search was re-
stricted to articles published in the English language.
Eligibility Criteria
Articles were included if they were comparative studies on du-
ration of postoperative antibiotics for complex appendicitis in 
adults and/or children. Complex appendicitis was defined as a 
gangrenous and/or perforated appendicitis or appendicitis with a 
pelvic or intra-abdominal abscess (IAA) [5]. Randomized con-
trolled trials, prospective and retrospective observational studies 
and case series were eligible for inclusion. Studies were excluded if 
the abstract revealed no relevance to the subject or if they were one 
of the following: case reports, letters, editorials, animal studies. For 
publications without an abstract, the full article was retrieved and 
assessed for eligibility. If full text was not available, even after con-
tacting the original author to request access to the date, the article 
was excluded. Studies describing preoperative prophylactic antibi-
otics or antibiotics as conservative treatment for acute appendicitis 
were outside the scope of the study. Studies reporting postopera-
tive antibiotic treatment prolonged beyond 5 days in both the in-
tervention and control group were outside the scope of this review 
as well, based on current practice in the Netherlands and the aim 
of this review to evaluate evidence for a shorter duration. If the 
duration of antibiotics was unclear or variable, the author was con-
tacted in order to retrieve exact durations. 
Study Selection
Two reviewers independently assessed the articles for inclusion 
by screening the titles and abstracts. All duplicates were removed. 
Full-text articles of possibly eligible studies were reviewed for in-
clusion. Excluded articles were recorded along with the reason for 
exclusion.
Data Extraction
Data on authors, country of origin, year of publication, study 
design, study population, definition of complex appendicitis, de-
tails on the duration of postoperative antibiotic treatment, route 
and type of antibiotic used, follow-up period, readmission, hospi-
tal stay, postoperative complications, IAA and surgical site infec-
tion (SSI) in particular were extracted by the first reviewer. The 
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second reviewer verified the data extraction. Postoperative antibi-
otic treatment durations were classified into the following dura-
tion categories based on what was reported in the selected studies: 
up to 5 days versus > 5 days, up to 3 days versus > 3 days and up to 
24 h versus > 24 h. This classification was made in such a way that 
a clear comparison could be made between a short and long course 
of postoperative antibiotic treatment. If no exact postoperative an-
tibiotic durations could be retrieved – for example, given only a 
minimum duration and variable prolongation given and overlap-
ping median durations reported for the short and long course 
groups – then they were excluded from the meta-analysis. We pro-
vided only descriptions of these studies. 
Quality Assessment
Two reviewers each independently assessed the level of evi-
dence of each paper, using the Grades of Recommendation, As-
sessment, Development and Evaluation (GRADE) tool by Co-
chrane [44]. The GRADE approach defines the quality of a body 
of evidence by consideration of within study risk of bias (method-
ology quality), directness of evidence, heterogeneity, precision of 
effect estimates, and risk of publication bias. 
Outcomes
The primary outcome was postoperative IAA after appendec-
tomy. Definitions of IAA in the included studies can be found in 
online supplementary Appendix S2. Secondary endpoints were 
SSI, LOS and readmission. 
Statistical Analysis
Risk ratios (RR) were calculated using a random-effects meta-
analysis model based on the DerSimonian-Liard method for esti-
mating the between-study variance in order to take into account 
any potential heterogeneity between the studies. The random-ef-
fects model accounts for the heterogeneity between the studies 
while at the same time larger samples with smaller standard errors 
receive more weight when calculating the overall RR. Forest plots 
were created for the primary outcome. Each forest plot shows the 
effect size of the individual studies and an overall pooled event rate 
with a confidence interval. Statistical analyses were conducted us-
ing Review Manager (RevMan) version 5.3 (Copenhagen: The 
Nordic Cochrane Centre, The Cochrane Collaboration) [45]. De-
scriptive statistics was used for secondary endpoints.
Results
Study Selection
A total of 1,612 articles were identified through the 
comprehensive electronic search. After reading titles and 
abstracts, 1,520 articles were excluded mostly reporting 
preoperative prophylaxis for appendectomy or evaluat-
ing different surgical approaches. Two additional articles 
were identified after manually scrutinizing reference lists. 
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(n = 94)
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with reasons
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• No complex
 appendicitis
• No duration of AB
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 duration vs. duration
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(n = 9)
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quantitative synthesis
(meta-analysis)
(n = 4)
Fig. 1. PRISMA flow diagram.
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Of the 94 full-text articles assessed for eligibility, 9 were 
included into this review describing outcome for 2,006 
patients with complex appendicitis. Figure 1 shows the 
preferred reporting items for systematic reviews and me-
ta-analyses flow diagram for systematic reviews. Charac-
teristics of the included studies are shown in Table 1.
Quality of Evidence Assessment
Quality of the included articles ranged from very 
low  to low. A detailed assessment of the quality of the 
available evidence using the GRADE tool is presented in 
Table 2.
Outcome Assessment
Intra-Abdominal Abscess
One study did not report IAA as an outcome [36], leav-
ing 8 studies that reported 138 IAAs in 1,596 patients 
(8.6%). Two articles compared different antibiotic strate-
gies dependent on clinical criteria without reporting exact 
durations in the intervention and control groups [10, 30]. 
We could not retrieve the exact duration data and there-
fore their data were not suitable for meta-analysis. Data 
from 5 remaining studies could be incorporated in meta-
analysis, including a total of 1,292 patients [8, 22, 35, 38]. 
The only RCT showed no events and therefore was left out 
of the analysis [34]. The last remaining study showed only 
data of ≤24 vs. > 24 h of antibiotic duration but included 
too less number of patients [37]. No funnel plots were pro-
vided due to the low number of included studies according 
to the recommendation of the Cochrane Network [45]. 
Up to 5 vs. > 5 days of postoperative antibiotic treatment: 
In the ≤5 days group, 49 of 986 patients (5%) had an IAA 
versus 34 of 261 patients (13%) in the > 5 days group. The 
overall RR estimate was 0.36 (95% CI 0.23–0.57; p < 
0.0001) in favour of ≤5 days postoperative antibiotics 
(Fig. 2). There was no heterogeneity between the studies.
Up to 3 vs. > 3 days of postoperative antibiotic treatment: 
In the ≤3 days group, 21 of 424 (5%) patients developed 
an IAA versus 62 of 823 (7.5%) in the > 3 days group. The 
overall RR estimate was 0.81 (95% CI 0.38–1.74; p = 0.59) 
in favour of ≤3 days of antibiotic treatment (Fig. 3). There 
was little heterogeneity between the studies.
Up to 24 vs. > 24 h of postoperative antibiotic treatment: 
Two studies reported outcomes after postoperative anti-
biotic treatment limited to 24 h or no postoperative treat-
ment at all [37, 38]. Due to the small number of patients, 
a meaningful meta-analysis was not possible. In only one 
of these studies, antibiotic duration of ≤24 h (n = 8) was 
directly compared with > 24 h (n = 44). The authors con-
cluded there was no significant difference in IAA forma-
tion (25 vs. 20.5% respectively, p = 1.000) [37]. The other 
study reported no IAA in the ≤24 h (n = 11) and 15% IAA 
in the > 24 h group (n = 67) [38].
Of the 2 remaining studies comparing variable dura-
tion protocols in patients with complex appendicitis, nei-
ther showed a statistically significant difference in the rate 
of IAA correlated to antibiotic duration. Details of the 
study protocols are displayed in Table 1 [10, 30].
Surgical Site Infection
Five of the included studies reported 38 SSIs among 
1,231 (3.1%) patients [8, 22, 30, 34, 36]. None demonstrat-
ed a statistically significant difference in (neither superfi-
cial nor deep) SSI rates between different duration groups. 
The available data was insufficient for meta-analysis.
Length of Hospital Stay 
Four studies reported LOS [8, 22, 30, 36]. Reported 
median LOS ranged from 4 to 7 days. Due to varying du-
rations of antibiotics in these studies, data was unsuitable 
for a useful pooled meta-analysis. All 4 studies demon-
strated significantly shorter LOS for the shorter course of 
antibiotics. In 3 studies, the difference was 1 day [22, 30, 
36] and in 1 study, the difference was 2 days [8]. 
Readmission 
Three studies together reported 100 readmissions 
among 919 patients (10.9%) [22, 30, 36]. None revealed a 
significant difference in the readmission rate between dif-
ferent duration groups. The data was unsuitable for meta-
analysis. 
Discussion
The present study shows that there is no clear associa-
tion between duration of postoperative antibiotic treat-
ment and the incidence of IAA after appendectomy for 
complex appendicitis. While RRs for IAA where in favour 
of ≤5 days of postoperative antibiotics compared to 
> 5 days, this could not be demonstrated for ≤3 days com-
pared to > 3 days. One could argue that antibiotics could be 
safely stopped after 3 days of intravenous treatment or pos-
sibly even earlier. However, all studies included in the me-
ta-analysis were observational studies and 2 out of 4 re-
ported very low IAA rate. Therefore, selection bias may 
have significantly influenced the present results. Less “fit” 
patients, for example, with more comorbidities, who were 
perhaps more at-risk for IAA to begin with, might have 
been prescribed longer courses compared to the patients 
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Table 1. Characteristics of all included studies
Reference Study design Participant Duration postop AB, n Follow-up IAA,
n (%)
SSI,
n (%)
LOS, days, 
median
(IQR)
Readmission,
n (%)
Basoli et al.
[34], 2008
(Italy)
Multicentre
randomized
trial
Adults (n = 45) with
localized secondary
peritonitis due to
appendicitis, with
improvement in
temperature, WBC
and presence of
abdominal sounds
at the third
postoperative day
Operation technique
and intraoperative
drain placement not
mentioned
3 days (22)
≥5 days (23)
AB IV: ertapenem
Not
reported
0
0
2 (9.1)
2 (8.7) 
Not
reported
Not
reported
Cho et al.
[35], 2016
(South Korea)
Single-centre
retrospective 
observational
study
Adults and children
(n = 496) with complex 
appendicitis treated by 
laparoscopic
appendectomy
A closed suction
drain was placed
when incomplete
source control
1–2 days (55)
3 days (128)
4 days (100)
5 days (103)
6 days (54)
>6 days (56) 
AB IV: cefotaxime and
metronidazole
Variable duration based
on surgeon’s preference
30 days 0
1 (0.8)
0
0
2 (3.7)
0
Not
reported
Not
reported
Not
reported
Hughes et al.
[38], 2013
(UK)
Single-centre
prospective
observational
study
Adults (n = 78) with
complex appendicitis
treated by laparoscopic 
appendectomy 
Intraoperative
drain inserted in
n = 50 (64%)
None (2)
≤24 h (9)
2–3 days (6)
4–5 days (18)
>5 days (43)
AB IV: piperacillin/tazobactam
AB oral: amoxicillin/clavulanic
acid
30 days 0
0
1 (16.7)
2 (11.1)
7 (16.3)
Not
reported
Not
reported
Not
reported
Kim et al.
[36], 2015
(USA)
Multicentre
retrospective
observational
study
Adults (n = 410) with
complex appendicitis
treated by laparoscopic 
appendectomy in
n = 343 (84%).
Intraoperative
drain inserted in
n = 48 (12%)
None (136)
≥0 (274)
AB: not described
Not
reported
Not
reported
5 (4%)
10 (4%)
4 (2–6)
5 (4–7)
11 (8)
33 (12)
Kimbrell et al.
[37], 2014
(USA)
Single-centre
retrospective
observational
study
Adults (n = 52) with
complex appendicitis
treated by laparoscopic 
appendicitis in
n = 34 (65%)
Intraoperative
drain inserted in
n = 15 (29%)
≤24 h (8)
>24 h (44)
AB IV and PO: piperacillin/
tazobactam, cefoxitin, moxifloxacin,
amoxicillin/clavulanic acid,
ciprofloxacin/metronidazole,
trimethoprim/sulfamethoxazole,
tobramycin and linezolid,
cefuroxime and clindamycin, and
vancomycin
Variable duration based on surgeon’s
preference
1 month 2 (25)
9 (20.5)
Not
reported
Not
reported
Not
reported
Van Rossem et al.
[8], 2014
(The Netherlands)
Single-centre
retrospective
observational
study
Adults (n = 267) with
complex appendicitis
treated by laparoscopic 
appendectomy in
n = 87 (33%)
Intraoperative drain
placement not
mentioned
3 days (135)
5 days (116)
6 days (1)
7 days (3)
8 days (1)
10 days (2)
Unknown (9)
AB IV: cefuroxime and
metronidazole
Not
reported
13 (9.6)
6 (5.2)
1 (100)
0
0
0
1 (11)
6 (4.4)
2 (1.7)
0
0
0
0
1 (11) 
Not
reported
Not
reported
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who showed swift postoperative recovery. Beside this po-
tential selection bias, the type of antibiotics differed be-
tween the studies and no separate analysis for children and 
adults could be performed. One study included patients 
who underwent open appendectomy as well as patients 
that underwent laparoscopic appendectomy. Stratification 
was not possible due to the low number of studies, patients 
and events. Hence, the efficacy of antibiotics for subgroups 
could not be investigated, which may have introduced bias. 
Due to a lack of high-level studies, no final conclusions can 
be drawn concerning the optimum duration, let alone the 
safety and efficacy of < 3 days of antibiotics. Reducing the 
duration from 5 to 3 days could already have major impli-
cations, as the majority of patients in the Netherlands and 
worldwide still receive antibiotics for 5 days after appen-
dectomy for a complex appendicitis [22, 23, 46]. This is 
instigated by the current guidelines of the Dutch Surgical 
Association (NVvH), the Surgical Infection Society and In-
fectious Diseases Society of America and the Dutch Work-
ing Party on Antibiotic Policy (SWAB) that recommend 
3–7, 4–7 and 5–14 days of postoperative antibiotics respec-
tively [18, 19, 21]. This review shows little evidence in sup-
port of the current guidelines. At a time when antimicro-
bial resistance is an increasingly urgent global health threat, 
the use of antibiotics should be minimized where possible. 
Resistance is a natural biological outcome of antibiotic use. 
Antibiotic overtreatment, however, increases the speed of 
emergence and selection of resistant bacteria [47, 48]. 
It is plausible that reducing the duration of antibiotic 
treatment may not increase the rate of IAA, as the develop-
ment of infectious complications following appendectomy 
is a multifactorial process. Many risk factors have been 
identified including preoperative C-reactive protein level, 
timing of appendectomy, technique of appendiceal stump 
closure, operation approach (laparoscopic versus open), 
the presence of a faecolith, longer operation time, simple 
versus complex appendicitis, body temperature, American 
Society of Anesthesiology classification, age, body mass in-
dex and gender [6, 14–17, 26, 49]. Recent studies provide 
support for the concept that beneficial effect of systemic 
antibiotic therapy after adequate source control during 
surgery is limited [33, 50]. A randomized controlled trial 
(“STOP-IT”) published in 2015 showed that after adequate 
source control for complicated intra-abdominal infec-
tions, outcomes after a short course of antibiotics (median 
4 days, n = 257) were similar after long course therapy (me-
Reference Study design Participant Duration postop AB, n Follow-up IAA,
n (%)
SSI,
n (%)
LOS, days, 
median
(IQR)
Readmission,
n (%)
Van Rossem et al.
[22], 2016
(The Netherlands)
Multicentre
prospective
observational
study
Adults and children
(n = 415) with complex 
appendicitis treated by 
laparoscopic
appendectomy
Intraoperative drain
placement not
mentioned
2–3 days (89)
4–5 days (225)
>5 days (101)
AB: usually a combination of
cephalosporin and metronidazole
30 days 6 (6.7)
20 (8.9)
24 (23.8)
1 (1)
4 (2)
4 (4)
4
5
7
6 (7)
27 (12)
10 (10)
Van Wijck et al.
[10], 2010
(The Netherlands)
Multicentre
retrospective
observational
study
Children (n = 149) with 
perforated appendicitis 
treated by laparoscopic 
appendectomy in n = 72 
(48%)
Intraoperative drain
placement not
mentioned
Median 5 days (68)
Variable duration based on clinical
grounds, minimum 5 days
Median 7 days (81)
Variable duration based on
CRP-level, minimum 5 days
AB IV: amoxicillin/clavulanic acid
and gentamycin
Not
reported
13 (19.1)
16 (19.8)
Not
reported
Not
reported
Not
reported
Yu et al.
[30], 2014
(New Zealand)
Single-centre 
prospective
propensity-
score matched 
study
Children (n = 94) years
with complex appendicitis
Operation technique and 
intraoperative drain
placement not
mentioned
Median 3 days IV (47)
Variable duration based on clinical
criteria, unclear duration additional
PO antibiotics Median 5 days IV (47)
Variable duration based on clinical
criteria, minimum 5 days IV, unclear
duration additional PO antibiotics
AB IV: amoxicillin, metronidazole and
gentamycin
30 days 6 (12.8)
8 (17.0)
1 (2)
0
4 (2)
5 (2)
6 (13)
7 (15)
Postop AB, postoperative antibiotics; IAA, intra-abdominal abscess; SSI, surgical site infection; LOS, length of hospital stay; readm, hospital readmission; IV, intravenous; PO, per 
os; CRP, C-reactive protein.
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Table 2. GRADE evidence profile of the included studies
Reference Quality assessment Quality
risk of bias inconsistency indirectness imprecision other
considerations
Basoli et al. [34] Seriousa Not serious Not serious Seriousb, c None ⨁⨁◯◯ 
Low
Cho et al. [35] Seriousd, e Not serious Not serious Seriousc Seriousf ⨁◯◯◯ 
Very low
Hughes et al. [38] Not serious Not serious Not serious Not serious Seriousf ⨁◯◯◯ 
Very low
Kim et al. [36] Seriousd Not serious Not serious Not serious Seriousf ⨁◯◯◯ 
Very low
Kimbrell et al. [37] Seriouse Not serious Not serious Not serious Seriousf ⨁◯◯◯ 
Very low
Van Rossem et al. [8] Not serious Not serious Not serious Not serious None ⨁⨁◯◯ 
Low
Van Rossem et al. [22] Not serious Not serious Not serious Not serious None ⨁⨁◯◯ 
Low
Van Wijck et al. [10] Seriouse Not serious Not serious Not serious None ⨁◯◯◯ 
Very low
Yu et al. [30] Not serious Not serious Not serious Not serious None ⨁⨁◯◯ 
Low
a No information provided on sequence generation or allocation concealment; loss to follow-up and protocol violations not further 
clarified.
b No report of power analysis for sample size calculation; small sample size.
c Risk of underreported outcome (low number of events).
d Exposure and outcome measurement not described, therefore not reproducible.
e No analysis on possible confounders (with detected inequalities at baseline).
f Unclear what determined the duration of antibiotic treatment per patient (either surgeons’ preference or not described).
GRADE, Grades of Recommendation, Assessment, Development and Evaluation.
Study or subgroup Events Total
>5 days≤5 days
Events Total Weight
RR
M-H, random (95% CI)
RR
M-H, random (95% CI)
van Rossem, 2016 [22]
Hughes, 2013 [38]
van Rossem, 2014 [8]
Cho, 2016 [35]
Total (95% CI)
Total events
Heterogeneity: Tau2 = 0.00; chi2 = 1.10, df = 3 (p = 0.78); I2 = 0%
Test for overall effect z = 4.41 (p < 0.0001)
26
3
19
1
49
314
35
251
386
986
24
7
1
2
34
101
43
7
110
261
78.3%
12.4%
5.8%
3.5%
100.0%
0.35 [0.21, 0.58]
0.53 [0.15, 1.89]
0.53 [0.08, 3.42]
0.14 [0.01, 1.56]
0.36 [0.23, 0.57]
1001010.10.01
Favours (≤5 days) Favours (>5 days)
Fig. 2. Meta-analysis of the RR of IAA development between patients with until 5 days of postoperative antibiotics treatment and pa-
tients with > 5 days of postoperative antibiotics treatment. RR, risk ratio.
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dian 8 days, n = 260). Rates of SSI, recurrent intra-abdom-
inal infection and death were similar in both groups, while 
the median duration of antibiotic treatment was signifi-
cantly shorter in the experimental group [33]. Although 
the premature closure of this trial for concerns of futility 
may have led to an underpowered study, the result is con-
sistent with the outcome of this review [51]. For several 
other types of infection (i.e., community-acquired pneu-
monia, pyelonephritis and cellulitis), clinical trials contin-
ually demonstrate that reduced course antibiotic treat-
ment is safe and effective as well [52]. 
Continuously, studies on complex appendicitis fail to 
show beneficial effects of prolonging postoperative anti-
biotic treatment. Aside from the results included in this 
review, several other studies (that fell just outside our se-
lection criteria) support this view [10, 26–30]. One ex-
ample is a randomized study by Fraser et al. [28] aimed at 
reducing IV antibiotics after appendectomy for complex 
appendicitis. The authors compared patients treated with 
a minimum of 5 days of IV antibiotics to patients treated 
with IV antibiotics until discharge criteria were met (no 
minimum). Though unfortunately no exact duration of 
antibiotics was reported, mean LOS was significantly re-
duced from 6 to 4 days, while IAA rates were similar in 
both groups [28]. Moreover, several studies in which dif-
ferent antibiotic agents are compared, both given for not 
more than 3 days, report rather acceptable rates of infec-
tious complications [48, 53–56]. 
A large Dutch prospective cohort study, included in 
this review, concluded that 3 days of postoperative anti-
biotics after surgery for complex appendicitis is safe: it did 
not result in a higher rate of complications compared to 
patients treated for 5 days [8]. However, in their analysis, 
the authors only included patients who received exactly 3 
or 5 days of antibiotics. Patients with deviant treatment 
duration were excluded. Although the study is fraught 
with a selection bias, several Dutch hospitals have already 
adjusted their practice to a standard of 3 days of postop-
erative antibiotics [23]. The outcomes of the present me-
ta-analyses support this movement, which is also in line 
with the minimum duration recommended in the Dutch 
guideline (2010). Limiting postoperative antibiotics to 
3 days of intravenous treatment is further supported by 
studies showing no benefit of additional oral antibiotics 
after initial intravenous administration [29, 31]. 
Unfortunately, this review has several limitations. Most 
of the included studies had a retrospective design. Only one 
study was a randomized controlled trial, with a small num-
ber of complex appendicitis patients (n = 45) and none had 
an IAA in the postoperative course [34]. Furthermore, the 
definitions used in the patient selection (for complex or 
perforated appendicitis) and in the study endpoints (for 
IAA and SSI) were not uniform among the studies, if de-
scribed at all (online suppl. Appendix S2). This may have 
introduced bias in the meta-analysis. Variability in defin-
ing complex appendicitis during appendectomy has been 
reported earlier by our group [23]. In addition, the com-
pleteness of adequate source control (like suction and ir-
rigation of the abdominal cavity), which is considered an 
important factor associated with infectious complications, 
was not reported in most studies. This may have intro-
duced clinical heterogeneity between the studies. Lastly, 
data regarding SSI, LOS and readmission rate was poorly 
reported and altogether insufficient for meta-analysis. 
These are important outcome measures for efficacy, safety 
and cost-effectiveness in the treatment of complex appen-
dicitis and should be reported in future research.
In conclusion, there is no clear evidence in favour of 
an optimal duration of postoperative antibiotic treatment 
for complex appendicitis. However, the present results 
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Fig. 3. Meta-analysis of the RR of IAA development between patients with until 3 days of postoperative antibiotics treatment and pa-
tients with > 3 days of postoperative antibiotics treatment. RR, risk ratio.
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may suggest that treatment for longer than 3 days is not 
significant more beneficial. Adequately powered, ran-
domized studies with clear definitions of the study popu-
lation and the endpoints are needed to define the optimal 
postoperative antibiotic regimen for complicated appen-
dicitis in children and adults. 
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